Gain access now

2022 Vizient biosimilar survey

The recent Vizient provider Biosimilar Survey indicated perspectives on the current landscape of biosimilars and what to anticipate with formulary changes in 2023 and beyond.

  • Approvals and what’s next
  • Importance of interchangeability and substitution
  • Role of payers in the adoption process

Access the report